UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | J | K | L | M | N | O | P | R | S | T | V | W | Z
Number of items: 143.

A

Ajzensztejn, D and Hegde, V and Lee, SM (2006) Tumour lysis syndrome following treatment with standard second-line docetaxel for non-small cell lung cancer. Journal of Clinical Oncology , 24 (15) 2389 - 2391.

Alonzi, R and Hoskin, P (2006) Functional imaging in clinical oncology: Magnetic resonance imaging- and computerised tomography-based techniques. CLINICAL ONCOLOGY , 18 (7) 555 - 570.

Arkenau, H-T (2006) 42nd annual meeting of the American society of clinical oncology, Atlanta, USA, 2006: Adjuvant treatment for colon and rectal cancer. Advances in Gastrointestinal Cancers , 4 (2) 21 - 22.

Arnould, S and Spanswick, VJ and Macpherson, JS and Hartley, JA and Thurston, DE and Jodrell, DI and Guichard, SM (2006) Time-dependent cytotoxicity induced by SJG-136 (NSC 694501): influence of the rate of interstrand cross-link formation on DNA damage signaling. Mol Cancer Ther , 5 (6) 1602 - 1609. 10.1158/1535-7163.MCT-06-0018.

Arnould, S and Spanswick, VJ and Macpherson, JS and Hartley, JA and Thurston, DE and Jodrell, DI and Guichard, SM (2006) Time-dependent cytotoxicity induced by SJU-136 (NSC 694501): influence of the rate of interstrand cross-link formation on DNA damage signaling. MOL CANCER THER , 5 (6) 1602 - 1609. 10.1158/1535-7163.MCT-06-0018.

Ayaru, L and Pereira, SP and Meyer, T and Davidson, BR and Burroughs, AK and Williams, R and Behboudi, S (2006) Alpha-fetoprotein specific CD4(+) T cell responses are unmasked during transarterial embolisation in hepatocellular carcinoma. In: GUT. (pp. A24 - A24). B M J PUBLISHING GROUP

Ayaru, L and Pereira, SP and Meyer, T and Davidson, BR and Burroughs, AK and Williams, R and Behboudi, S (2006) Alpha-fetoprotein specific CD4+ T cell responses are unmasked during transarterial embolisation in hepatocellular carcinoma. In: JOURNAL OF HEPATOLOGY. (pp. S11 - S11). ELSEVIER SCIENCE BV

B

Begent, R (2006) Developing Integrated Informatics Platform for Cancer Research. In: Nagl, S, (ed.) Cancer Bioinformatics: From Therapy Design to Treatment. (45 - 55). John Wiley & Sons: Chichester.

Beresford, M and Sanghera, B and Wong, WL and Makris, A (2006) Imaging of primary breast cancer with F-18-fluorodeoxythymidine PET-CT reveals heterogeneity of proliferation throughout the tumour. SPRINGER, 233 SPRING STREET, NEW YORK, NY 10013 USA

Beresford, MJ and Burcombe, R and Ah-See, ML and Stott, D and Makris, A (2006) Pre-treatment haemoglobin levels and the prediction of response to neoadjuvant chemotherapy in breast cancer. CLINICAL ONCOLOGY , 18 (6) 453 - 458.

Beresford, MJ and Chin, Y and Burcombe, Y and Ah-See, M and Makris, A (2006) Clinical response assessment after 2 cycles of neoadjuvant chemotherapy for primary breast cancer fails to predict for final clinical response, but does predict for pathological complete response. In: Journal of Clinical Oncology. (pp. 44S - 44S).

Beresford, MJ and Harris, AL and Ah-See, M and Daley, F and Padhani, AR and Makris, A (2006) The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer. BRITISH JOURNAL OF CANCER , 95 (12) 1683 - 1688.

Beresford, MJ and Padhani, AP and Taylor, NJ and Ah-See, M-L and Stirling, JJ and Makris, A and d'Arcy, JA and Collins, DJ (2006) Inter- and intraobserver variability in the evaluation of dynamic breast cancer MRI. Journal of Magnetic Resonance Imaging , 24 (6) 1316 - 1325. 10.1002/jmri.20768.

Beresford, MJ and Wilson, GD and Makris, A (2006) Measuring proliferation in breast cancer: practicalities and applications. Breast Cancer Research , 8 (6)

Bielack, S and Sydes, M and Butterfass-Bahloul, T and Anninga, J and Benninger-Doring, G and Calaminus, G and Dhooge, KC and Eriksson, M and Holliday, A and Hogendoorn, P and Kevric, M and Kuhne, T and Marina, N and Nielsen, O and Oellers, A and Papai, Z and Smeland, S and Tarkkanen, M and Whelan, J and Zoubek, A and Bernstein, M (2006) Successful multinational implementation of the European and American Osteosarcoma study EURAMOS-1 within the European Science Foundation's ECT-EUROCORES scheme. In: EMSOS, Moscow May 2006.

Blay, J and Le, CA and Whelan, J and Van, OA and Ray-Coquard, I and Judson, I and Hogendoorn, P and Marreaud, S and Hermans, C and Van, GM (2006) Gefitinib in second line treatment of metastatic or locally advanced synovial sarcoma expressing HER1: A phase II trial of the EORTC Soft Tissue and Bone Sarcoma Group. In: ASCO, Atlanta June 2006.

Blay, J and Le Cesne, A and Whelan, J and Van Oosterom, A and Ray-Coquard, I and Judson, L and Hogendorn, P and Marreaud, S and Hermans, C and Van Glabbeke, M (2006) Gefitinib in second line treatment of metastatic or locally advanced synovial sarcoma expressing HER1: A phase II trial of EORTC Soft Tissue and Bone Sarcoma Group. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 524S - 524S). AMER SOC CLINICAL ONCOLOGY

Boone, JJM and Hochhauser, D and Hartley, JA (2006) Modulation of the repair of cisplatin-induced DNA interstrand crosslinks by trastuzumab. In: EJC SUPPL. (pp. 151 - 151). PERGAMON-ELSEVIER SCIENCE LTD

Bourhis, J and Overgaard, J and Audry, H and Ang, KK and Saunders, M and Bernier, J and Horiot, JC and Le Maitre, A and Pajak, TF and Poulsen, MG and O'Sullivan, B and Dobrowsky, W and Hliniak, A and Skladowski, K and Hay, JH and Pinto, LH and Fallai, C and Fu, KK and Sylvester, R and Pignon, JP (2006) Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet. , 368 (9538) 843 - 854. 10.1016/S0140-6736(06)69121-6.

Brooks, S and Daley, F and Johns, P and Brandner, S and Short, SC (2006) Pescadillo and CYP1B1: Novel metabolic targets in glioma. In: RADIOTHERAPY AND ONCOLOGY. (pp. S72 - S73). ELSEVIER IRELAND LTD

Buchmueller, K and Bailey, S and Matthews, D and Register, J and Bruce, CD and O'Hare, C and Hartley, J and Nguyen, B and Wilson, D and Lee, M (2006) Molecular recognition of polyamides with DNA: A study on the strong binding of f-ImPyIm to its cognate DNA, ACGCGT. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. (pp. 678 - ?).

Buchmueller, KL and Bailey, SL and Matthews, DA and Taherbhai, ZT and Register, JK and Davis, ZS and Bruce, CD and O'Hare, C and Hartley, JA and Lee, M (2006) Physical and structural basis for the strong interactions of the -ImPy- central pairing motif in the polyamide f-ImPyIm. BIOCHEMISTRY-US , 45 (45) 13551 - 13565. 10.1021/bi061245c.

Buffa, FM and Bentzen, SM and Atasoy, BM and Daley, FM and Richman, PI and Dische, S and Wilson, GD and Saunders, MI (2006) The response of head and neck tumours to radiotherapy may be influenced by the interaction between cell proliferation and vascularization. In: RADIOTHERAPY AND ONCOLOGY. (pp. S65 - S66).

Burcombe, R and Wilson, GW and Dowsett, M and Khan, I and Richman, PI and Daley, F and Detre, S and Makris, A (2006) Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer. Breast Cancer Research , 8 (3) R31 - ?. 10.1186/bcr1508.

Burton, C and Linch, D and Hoskin, P and Milligan, D and Dyer, MJS and Hancock, B and Mouncey, P and Smith, P and Qian, W and MacLennan, K and Jack, A and Webb, A and Cunningham, D (2006) A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma. BRITISH JOURNAL OF CANCER , 94 (6) 806 - 813.

C

Carnell, DM and Smith, RE and Daley, FM and Saunders, MI and Bentzen, SM and Hoskin, PJ (2006) An immunohistochemical assessment of hypoxia in prostate carcinoma using pimonidazole: Implications for radioresistance. International Journal of Radiation Oncology Biology Physics , 65 (1) 91 - 99.

Caroline, R (2006) I was saved from death by cells harvested from my bones. The Daily Mail

Cave, J and Davis, B and Lee, SM and Jones, A (2006) A randomised controlled trial comparing symptom-based and tumour-based teaching for undergraduates medical students. In: (Proceedings) 2006 NCRI Cancer Conference, Birmingham.. (pp. 192 - ?). Annals of Oncology

Cerone, MA and Londoño-Vallejo, JA and Autexier, C (2006) Mutated telomeres sensitize tumor cells to anticancer drugs independently of telomere shortening and mechanisms of telomere maintenance. Oncogene , 25 (56) 7411 - 7420. 10.1038/sj.onc.1209727.

Cerone, MA and Londoño-Vallejo, JA and Autexier, C (2006) Telomerase inhibition enhances the response to anticancer drug treatment in human breast cancer cells. Mol Cancer Ther , 5 (7) 1669 - 1675. 10.1158/1535-7163.MCT-06-0033.

Chang, JC and Makris, A and Hilsenbeck, SJ and Hackett, JR and Jeong, J and Liu, M and Baker, J and Sexton, M and Osborne, CK and Shak, S (2006) Gene expression profiles in formalin-fixed, paraffin-embedded (FFPE) core biopsies predict docetaxel chemosensitivity. In: Journal of Clinical Oncology. (pp. 12S - 12S).

Channel, 5N (2006) Cancer drug battle. UNSPECIFIED

Chin, Y and Ravichandran, D and Makris, A (2006) Exemestane after non-steroidal aromatase inhibitors for post-menopaual women with advanced breast cancer. In: european Journal of Cancer. (pp. 167 - ?).

Chin, YS and Bullard, J and Bryant, L and Bownes, P and Ostler, P and Hoskin, PJ (2006) High dose rate iridium-192 brachytherapy as a component of radical radiotherapy for the treatment of localised prostate cancer. CLINICAL ONCOLOGY , 18 (7) 474 - 479.

Chong, G and Bhatnagar, A and Cunningham, D and Cosgriff, TM and Harper, PG and Steward, W and Bridgewater, J and Moore, M and Cassidy, J and Coleman, R and Coxon, F and Redfern, CH and Jones, JJ and Hawkins, R and Northfelt, D and Sreedharan, S and Valone, F and Carmichael, J (2006) Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancer. Ann Oncol , 17 (3) 437 - 442. 10.1093/annonc/mdj090.

Chow, E and Hoskin, P and van der Linden, Y and Bottomley, A and Velikova, G (2006) Quality of life and symptom end points in palliative bone metastases trials. ELSEVIER SCIENCE LONDON, 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND

Chow, E and Hoskin, PJ and Wu, J and Roos, D and van der Linden, Y and Hartsell, W and Vieth, R and Wilson, C and Pater, J (2006) A phase III international randomised trial comparing single with multiple fractions for re-irradiation of painful bone metastases: National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) SC 20. ELSEVIER SCIENCE LONDON, 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND

Cleator, S and Makris, A and Powles, T (2006) Response to letter "Analysis of breast cancer survival by clinical response to neoadjuvant chemoendocrine therapy" by Bogaerts et al. (Ann Oncol 2006; 17 : 352-353). UNSPECIFIED

D

Daniels, S and Statham, P and Globe, D and Seddon, B and Whelan, J (2006) Piloting a novel method of administration – Moving inpatient treatments to ambulatory care. In: British Oncology Pharmacists Association, Bournemouth October 2006.

Dische, S and Rojas, A and Saunders, M (2006) What can be learnt from a final follow up study of the chart pilot study? In: Radiotherapy & Oncology. (pp. S131 - S131).

Donovan, E and Coles, C and Westbury, C and Yarnold, J (2006) Breast. In: External Beam Therapy. Oxford University Press

E

El, EE and Dearling, J and Huhalov, A and Robson, P and Neri, D and van, DGA and Zardi, L and Begent, RHJ and Pedley, RB (2006) Targeting the tumour vasculature: therapeutic efficacy of a 131I-labeled antibody against the ED-B domain of fibronectin. In: (Proceedings) NCRI Cancer Conference proceedings. (pp. 63 - ?).

El, EE and Dearling, J and Huhalov, A and Robson, P and Neri, D and van, DGA and Zardi, L and Begent, RHJ and Pedley, RB (2006) Targeting tumour vasculature in human colorectal xenografts using an antibody against the extra-domain B of fibronectin. BACR/BMS Tumour vasculature: New targets and Therapies. In: Angiogenesis. (pp. 18 - ?).

F

Flores, L and Staples, A and Mackay, H and Howard, C and Uthe, P and Sexton, J and Buchmueller, K and O'Hare, C and Hochhauser, D and Hartley, J and Wilson, D and Lee, M (2006) Synthesis and evaluation of LVF-I-141: An intercalator-polyamide hairpin designed to target the inverted CCAAT box 2 in the topoisomerase II alpha promoter. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY , 231 ? - ?.

Flores, LV and Staples, AM and Mackay, H and Howard, CM and Uthe, PB and Sexton, JS and Buchmueller, KL and Wilson, WD and O'Hare, C and Kluza, J and Hochhauser, D and Hartley, JA and Lee, M (2006) Synthesis and evaluation of an intercalator-polyamide hairpin designed to target the inverted CCAAT box 2 in the topoisomerase II alpha promoter. CHEMBIOCHEM , 7 (11) 1722 - 1729. 10.1002/cbic.200600155.

Ford, HER and Yap, YS and Miles, DW and Makris, A and Hall, M and Miller, L and Harries, M and Smith, IE and Johnston, SRD (2006) A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer. Cancer Chemotherapy and Pharmacology , 58 (6) 809 - 815.

Fox, J and Alabassi, A and Patkar, V and Rose, T and Black, E (2006) An ontological approach to modelling tasks and goals. COMPUT BIOL MED , 36 (7-8) 837 - 856. 10.1016/j.compbiomed.2005.04.011.

Fox, J and Patkar, V and Thomson, R (2006) Decision support for health care: the PROforma evidence base. Inform Prim Care , 14 (1) 49 - 54.

Friedmann, BJ and Caplin, M and Savic, B and Shah, T and Lord, CJ and Ashworth, A and Hartley, JA and Hochhauser, D (2006) Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatment. MOL CANCER THER , 5 (2) 209 - 218. 10.1158/1535-7163.MCT-05-0239.

G

Glynne-Jones, R and Grainger, J and Harrison, M and Ostler, P and Makris, A (2006) Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious? BRITISH JOURNAL OF CANCER , 94 (3) 363 - 371.

Graham, J and Wagner, K and Plummer, R and Wiedenmann, B and Cassidy, J and Kowal, K and McCoy, C and Calvert, H (2006) Phase I dose-escalation study of novel oral multi-target tumor growth inhibitor (MTGI) ZK 304709 administered daily for 7 days of a 21-day cycle to patients with advanced solid tumors. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 97S - 97S). AMER SOC CLINICAL ONCOLOGY

Green, AJ and Begent, RHJ (2006) Generation of voxel phantoms to investigate the effect of statistical noise on image analysis programs. In: European Journal of Nuclear Medicine & Molecular Imaging. (pp. S319 - ?).

Green, AJ and Begent, RHJ (2006) Generation of voxel phantoms to investigate the effect of statistical noise on image analysis programs. EUR J NUCL MED MOL I , 33 S319 - S319.

Gupta, N and Saleem, A and Kotz, B and Osman, S and Aboagye, EO and Phillips, R and Vernon, C and Wasan, H and Jones, T and Hoskin, PJ and Price, PM (2006) Carbogen and nicotinamide increase blood flow and 5-fluorouracil delivery but not 5-fluorouracil retention in colorectal cancer metastases in patients. CLINICAL CANCER RESEARCH , 12 (10) 3115 - 3123.

H

Hamaguchi, A and Suggitt, M and Howard, PW and Gregson, SJ and Kasprzyk, PG and Thurston, DE and Hartley, JA (2006) DNA cross-linking and in vivo antitumour activity of the extended pyrrolo[2,1-c][1,4]benzodiazepine dimer SG2057 (DRG-16). In: EJC SUPPL. (pp. 96 - 96). PERGAMON-ELSEVIER SCIENCE LTD

Harland, SJ and Daugaard, G and Horwich, A and Mead, GM and Fossa, SD and Sokal, M and Morgenstern, D and Oliver, R and Cook, PA and Stenning, SP and National, CRITCCSG (2006) The familial influence on bilateral testicular germ cell cancer: Medical Research Council study TER2. In: Journal of Clinical Oncology. (pp. 239S, 4590 - ?).

Ho, E and Vassileva, V and Lim-Soo, P and Allen, C and Piquette-Miller, M (2006) Impact of localized, sustained delivery of paclitaxel on the in vitro and in vivo regulation of P-glycoprotein. In: CLINICAL PHARMACOLOGY & THERAPEUTICS. (pp. P11 - P11). MOSBY, INC

Howard, PW and Chen, Z and Gregson, SJ and Stephenson, M and Klee, S and Hartley, JM and Subur, G and Hartley, JA and Thurston, DE (2006) The design, synthesis and biological evaluation of a set of C2-aryl substituted pyrrolo[2,1-c][1,4]benzodiazepine dimers. EJC SUPPL , 4 (12) 95 - 95.

Howard, PW and Tiberghien, A and Gregson, SJ and Kang, GD and Stephenson, M and Kiakos, K and Klee, S and Hartley, JM and Hartley, JA and Thurston, DE (2006) Design, synthesis and evaluation of extended heterocycle linked C81C8 ' pyrrolo[2,1-c][1,4]benzodiazepine DNA cross-linking agents. In: EJC SUPPL. (pp. 93 - 93). PERGAMON-ELSEVIER SCIENCE LTD

Hughes, R and Glynne-Jones, R and Grainger, J and Richman, P and Makris, A and Harrison, M and Ashford, R and Harrison, RA and Livingstone, JI and McDonald, PJ and Meyrick, TJ and Mitchell, IC and Northover, JM and Phillips, R and Wallace, M and Windsor, A and Novell, JR (2006) Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision? International Journal of Colorectal Disease , 21 (1) 11 - 17.

J

Jagsi, R and Makris, A and Goldberg, S and Taghian, A (2006) Intra-European differences in the radiotherapeutic management of breast cancer: A survey study. CLINICAL ONCOLOGY , 18 (5) 369 - 375.

Jones, SF and Plummer, ER and Burris, HA and Razak, AR and Meluch, AA and Bowen, CJ and Williams, DH and Hodge, JP and Dar, MM and Calvert, AH (2006) Phase I study of ispinesib in combination with carboplatin in patients with advanced solid tumors. JOURNAL OF CLINICAL ONCOLOGY , 24 (18) 85S - 85S.

Juergens, C and Weston, C and Lewis, I and Whelan, J and Paulussen, M and Oberlin, O and Michon, J and Zoubek, A and Juergens, H and Craft, A (2006) Safety Assessment of Intensive Induction With Vincristine, Ifosfamide, Doxorubicin, and Etoposide (VIDE) in the Treatment of Ewing Tumors in the EURO-E.W.I.N.G. 99 Clinical Trial. Pediatric Blood and Cancer , 47 (1) 22 - 29.

Julia, LS (2006) You Don't Have to Smoke to Get Lung Cancer. Sunday Telegraph, Stella Magazine

K

Kaufmann, M and Hortobagyi, GN and Goldhirsch, A and Scholl, S and Makris, A and Valagussa, P and Blohmer, JU and Eiermann, W and Jackesz, R and Jonat, W and Lebeau, A and Loibl, S and Miller, W and Seeber, S and Semiglazov, V and Smith, R and Souchon, R and Stearns, V and Untch, M and von Minckwitz, G (2006) Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: An update. JOURNAL OF CLINICAL ONCOLOGY , 24 (12) 1940 - 1949.

Khanduri, S and Gerrard, G and Barton, R and Mulvenna, P and Lee, SM (2006) Clinical Trials assessing the optimal management of brain metastases-the state of play. Clinical Oncology , 18 (10) 744 - 746.

Khoja, L and Mulyati, M and Lee, SM (2006) Secondline chemotherapy in NSCLC. Lung Cancer in Practice , 3 (1) 6 - 7.

Kluza, J and Mazinghien, R and Irwin, H and Hartley, JA and Bailly, C (2006) Relationships between DNA strand breakage and apoptotic progression upon treatment of HL-60 leukemia cells with tafluposide or etoposide. ANTI-CANCER DRUG , 17 (2) 155 - 164.

Kogelberg, H and Sharma, SK and Qureshi, U and Tolner, B and Lowdell, M and Shabakhti, H and Robson, M and Pedley, RB and Begent, RHJ and Chester, KA (2006) Clearance mechanism of a mannoseylated antibody enzyme fusion protein used in experimental cancer therapy. In: (Proceedings) NCRI Cancer Conference Proceedings. (pp. 65 - ?).

Kogelberg, H and Sharma, SK and Qureshi, U and Tolner, B and Lowdell, M and Shahbakhti, H and Robson, M and Pedley, RB and Begent, RHJ and Chester, KA (2006) Clearance Mechanism Of A Mannosylated Antibody-Enzyme Fusion Protein Used In Experimental Cancer Therapy. In: (Proceedings) NCRI Cancer Conference Proceedings.

Koukourakis, MI and Bentzen, SM and Giatromanolaki, A and Wilson, GD and Daley, FM and Saunders, MI and Dische, S and Sivridis, E and Harris, AL (2006) Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. Journal of Clinical Oncology , 24 (5) 727 - 735.

L

Ladenstein, R and Whelan, J and Oberlin, O and Weston, C and Jurgens, H (2006) Multivariate analysis based risk grouping of Ewing tumours with extrapulmonary metastatic disease. Results from the EURO EWING 99 Study. In: SIOP XXXVII meeting, Geneva Sept 2006. Ped Blood Cancer 2006;47(4):369.

Lai, CSL and Boshoff, C and Falzon, M and Lee, SM (2006) Complete response to erlotinib therapy in brain metastases from recurrent NSCLC. Thorax , 61 (1) 91 - ?.

Lambros, MB and Simpson, PT and Jones, C and Natrajan, R and Westbury, C and Steele, D and Savage, K and Mackay, A and Schmitt, FC and Ashworth, A and Reis-Filho, JS (2006) Unlocking pathology archives for molecular genetic studies: a reliable method to generate probes for chromogenic and fluorescent in situ hybridization. Lab Invest , 86 (4) 398 - 408. 10.1038/labinvest.3700390.

Last, K and Maharaj, L and Perry, J and Strauss, S and Fitzgibbon, J and Lister, TA and Joel, S (2006) The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours. Ann Oncol , 17 , Article 5.

Le, NM and Sielaff, AM and Cooper, AJ and Mackay, H and Brown, T and Kotecha, M and O'Hare, C and Hochhauser, D and Lee, M and Hartley, JA (2006) Binding of f-PIP, a pyrrole- and imidazole-containing triamide to the inverted CCAAT box-2 of the topoisomerase II alpha promoter and modulation of gene expression in cells. Bioorganic and Medicinal Chemistry Letters , 16 (24) 1661 - 1664.

Le, NM and Sielaff, AM and Cooper, AJ and Mackay, H and Brown, T and Kotecha, M and O'Hare, C and Hochhauser, D and Lee, M and Hartley, JA (2006) Binding of f-PIP, a pyrrole- and imidazole-containing triamide to the inverted CCAAT box-2 of the topoisomerase II alpha promoter and modulation of gene expression in cells. BIOORG MED CHEM LETT , 16 (24) 6161 - 6164. 10.1016/j.bmcl.2006.09.043.

Lee, SM (2006) Is EGFR expression important in non-small cell lung cancer? Thorax , 61 (2) 98 - 99.

Louise, J (2006) Thalidomide makes a comeback-but at what cost? Morning Star

M

Maharaj, L and Popat, R and Chahwan, A and Lister, AT and Cavenagh, JD and Middleton, B and Rioja, A and Marson, C and Joel, SP (2006) The novel HDAC inhibitor UCL67022 is highly potent in multiple myeloma and non-Hodgkin's lymphoma and is enhanced by bortezomib. In: BLOOD. (pp. 735A - 735A). AMER SOC HEMATOLOGY

Marelli, L and Stigliano, R and Triantos, C and Senzolo, M and Cholongitas, E and Davies, N and Yu, D and Meyer, T and Patch, DW and Burroughs, AK (2006) Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. Cancer Treat Rev , 32 (8) 594 - 606. 10.1016/j.ctrv.2006.08.002.

Masterson, LA and Spanswick, VJ and Hartley, JA and Begent, RH and Howard, PW and Thurston, DE (2006) Synthesis and biological evaluation of novel pyrrolo[2,1-c][1,4]benzodiazepine prodrugs for use in antibody-directed enzyme prodrug therapy. BIOORG MED CHEM LETT , 16 (2) 252 - 256. 10.1016/j.bmcl.2005.10.017.

Masterson, LA and Spanswick, VJ and Hartley, JA and Begent, RH and Howard, PW and Thurston, DE (2006) Synthesis and biological evaluation of novel pyrrolo[2,1-c][1,4]benzodiazepine prodrugs for use in antibody-directed enzyme prodrug therapy. Bioorganic and Medicinal Chemistry Letters , 16 (2) 252 - 256. 10.1016/j.bmcl.2005.10.017.

Mayer, A and Francis, RJ and Sharma, SK and Tolner, B and Springer, CJ and Martin, J and Boxer, GM and Bell, J and Green, AJ and Hartley, JA and Cruickshank, C and Wren, J and Chester, KA and Begent, RH (2006) A Phase I Study of Single Administration of Antibody-Directed Enzyme Prodrug Therapy with the Recombinant Anti-Carcinoembryonic Antigen Antibody-Enzyme Fusion Protein MFECP1 and a Bis-Iodo Phenol Mustard Prodrug. Clinical Cancer Research , 12 (21) 6509 - 6516.

Mayer, A and Francis, RJ and Sharma, SK and Tolner, B and Springer, CJ and Martin, J and Boxer, GM and Bell, J and Green, AJ and Hartley, JA and Cruickshank, C and Wren, J and Chester, KA and Begent, RHJ (2006) A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug. CLIN CANCER RES , 12 (21) 6509 - 6516. 10.1158/1078-0432.CCR-06-0769.

McGurk, CJ and Cummings, M and Koberle, B and Hartley, JA and Oliver, RT and Masters, JR (2006) Regulation of DNA repair gene expression in human cancer cell lines. J CELL BIOCHEM , 97 (5) 1121 - 1136. 10.1002/jcb.20711.

McTiernan, A and Driver, D and Michelagnoli, MP and Kilby, AM and Whelan, JS (2006) High dose chemotherapy with bone marrow or peripheral stem cell rescue is an effective treatment option for patients with relapsed or progressive Ewing's sarcoma family of tumours. ANN ONCOL , 17 (8) 1301 - 1305. 10.1093/annonc/mdl108.

McTiernan, A and Meyer, T and Michelagnoli, MP and Lewis, I and Whelan, JS (2006) A phase I/II study of doxorubicin, ifosfamide, etoposide and interval methotrexate in patients with poor prognosis osteosarcoma. PEDIATR BLOOD CANCER , 46 (3) 345 - 350. 10.1002/pbc.20562.

McTiernan, A and Whelan, J and Leahy, M and Woll, PJ and Judson, I (2006) A phase II nonrandomised open-label study of liposomal daunorubicin (DaunoXome) in advanced soft tissue sarcoma. Sarcoma , 2006
An open access publication

McTiernan, AM and Cassoni, AM and Driver, D and Michelagnoli, MP and Kilby, AM and Whelan, JS (2006) Improving Outcomes After Relapse in Ewing’s Sarcoma: Analysis of 114 Patients From a Single Institution. Sarcoma , 2006 1 - 8.
An open access publication

Mita, MM and Ochoa, L and Rowinsky, EK and Kuhn, J and Schwartz, G and Hammond, LA and Patnaik, A and Yeh, IT and Izbicka, E and Berg, K and Tolcher, AW and Arkenau, T and Cunningham, D (2006) A Phase I, pharmacokinetic and biologic correlative study of oblimersen sodium (GenasenseTM, G3139) and irinotecan in patients with metastatic colorectal cancer. Advances in Gastrointestinal Cancers , 4 (1) 20 - 21.

Mudie, NY and Swerdlow, AJ and Higgins, CD and Smith, P and Qiao, ZK and Hancock, BW and Hoskin, PJ and Linch, DC (2006) Risk of second malignancy after non-Hodgkin's lymphoma: A British cohort study. J CLIN ONCOL , 24 (10) 1568 - 1574. 10.1200/JCO.2005.04.2200.

N

Ng, QS and Goh, V and Fichte, H and Klotz, E and Fernie, P and Saunders, MI and Hoskin, PJ and Padhani, AR (2006) Lung cancer perfusion at multi-detector row CT: Reproducibility of whole tumor quantitative measurements. RADIOLOGY , 239 (2) 547 - 553.

O

O'Donnell, P and Diss, TC and Whelan, J and Flanagan, AM (2006) Synovial sarcoma with radiological appearances of primitive neuroectodermal tumour/Ewing sarcoma: differentiation by molecular genetic studies. Skeletal Radiology , 35 (4) 345 - 350.

O'Donnell, P and Diss, TC and Whelan, J and Flanagan, AM (2006) Synovial sarcoma with radiological appearances of primitive neuroectodermal tumour/Ewing sarcoma: differentiation by molecular genetic studies. SKELETAL RADIOL , 35 (4) 233 - 239. 10.1007/s00256-005-0006-z.

P

Pankhurst, T and Howie, AJ and Adu, D and Wallace, DMA and Lipkin, GW (2006) Incidental neoplasms in renal biopsies. NEPHROLOGY DIALYSIS TRANSPLANTATION , 21 (1) 64 - 69. 10.1093/ndt/gfi149.

Patkar, V and Hurt, C and Steele, R and Love, S and Purushotham, A and Williams, M and Thomson, R and Fox, J (2006) Evidence-based guidelines and decision support services: a discussion and evaluation in triple assessment of suspected breast cancer. BRIT J CANCER , 95 (11) 1490 - 1496. 10.1038/sj.bjc.6603470.

Perisoglou, M and Seddon, B and Daniels, S and Mayne, N and Whelan, J (2006) Incidence of delays in methotrexate toxicity in treatment of osteosarcoma. In: SIOP XXXVII meeting, Geneva Sept 2006. Ped Blood Cancer 2006;47(4):511.

Plummer, R and Lorigan, P and Evans, J and Steven, N and Middleton, M and Wilson, R and Snow, K and Dewji, R and Calvert, H (2006) First and final report of a phase II study of the poly(ADP-ribose) polymerase (PARP) inhibitor, AGO14699, in combination with temozolomide (TMZ) in patients with metastatic malignant melanoma (MM). In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 456S - 456S). AMER SOC CLINICAL ONCOLOGY

Plummer, R and Vidal, L and Li, L and Shaw, H and Perrett, R and Shahidi, M and Amelsberg, A and Temple, G and Calvert, H and de Bono, J (2006) Phase I study of BIBW2992, an oral irreversible dual EGFR/HER2 inhibitor, showing activity in tumours with mutated EGFR. EJC SUPPL , 4 (12) 173 - 174.

Pors, K and Shnyder, SD and Teesdale-Spittle, PH and Hartley, JA and Zloh, M and Searcey, M and Patterson, LH (2006) Synthesis of DNA-directed pyrrolidinyl and piperidinyl confined alkylating chloroalkylaminoanthraquinones: Potential for development of tumor-selective N-oxides. J MED CHEM , 49 (24) 7013 - 7023. 10.1021/jm0608154.

Porschen, R and Kubicka, S and Grothey, A and Grateven, U and Kretzschmar, A and Greil, R and Freier, W and Seufferlein, T and Arkenau, H and Hinke, A and Schmoll, H and Schmiegel, W (2006) Final results of a randomized comparison of infusional 5-fluorouracil/leucovorin plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) in metastatic colorectal carcinoma (MCRC). In: GASTROENTEROLOGY. (pp. A582 - A582). W B SAUNDERS CO-ELSEVIER INC

Purnell, B and Lingerfelt, B and Scott, A and Townes, H and Summerville, K and Hudson, S and Kiakos, K and Hartley, JA and Lee, M (2006) Novel (S)-(-)- and R-(+)-seco-iso-cyclopropylfurano[e]indoline-5,6,7-trimethoxyindole-2-carboxamide (iso-CFI) analogs of duocarmycin C2: synthesis and biological evaluation. Med Chem , 2 (2) 139 - 146.

Purnell, B and Sato, A and O'Kelley, A and Price, C and Summerville, K and Hudson, S and O'Hare, C and Kiakos, K and Asao, T and Lee, M and Hartley, JA (2006) DNA interstrand crosslinking agents: Synthesis, DNA interactions, and cytotoxicity of dimeric achiral seco-amino-CBI and conjugates of achiral seco-amino-CBI with pyrrolobenzodiazepine (PBD). BIOORG MED CHEM LETT , 16 (21) 5677 - 5681. 10.1016/j.bmcl.2006.08.005.

R

Rades, D and Stalpers, LJA and Schulte, R and Veninga, T and Basic, H and Engenhart-Cabilic, R and Schild, SE and Hoskin, PJ (2006) Defining the appropriate radiotherapy regimen for metastatic spinal cord compression in non-small cell lung cancer patients. EUROPEAN JOURNAL OF CANCER , 42 (8) 1052 - 1056.

Rades, D and Stalpers, LJA and Veninga, T and Hoskin, PJ (2006) Spinal reirradiation after short-course RT for metastatic spinal cord compression. International Journal of Radiation Oncology Biology Physics , 63 (3) 872 - 875.

Rades, D and Stalpers, LJA and Veninga, T and Rudat, V and Schulte, R and Hoskin, PJ (2006) Evaluation of functional outcome and local control after radiotherapy for metastatic spinal cord compression in patients with prostate cancer. The Journal of Urology , 175 (2) 552 - 556.

Rades, D and Walz, J and Stalpers, LJA and Veninga, T and Schulte, R and Obralic, N and Wildfang, I and Engenhart-Cabilic, R and Hoskin, PJ and Schild, SE (2006) Short-course radiotherapy (RT) for metastatic spinal cord compression (MSCC) due to renal cell carcinoma: Results of a retrospective multi-center study. EUROPEAN UROLOGY , 49 (5) 846 - 852.

Ranson, M and Middleton, MR and Bridgewater, J and Lee, SM and Dawson, M and Jowle, D and Halbert, G and Waller, S and McGrath, H and Gumbrell, L and McElhinney, RS and Donnelly, D and McMurry, TB and Margison, GP (2006) Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA-alkyltransferase: phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumors. Clin Cancer Res , 12 (5) 1577 - 1584. 10.1158/1078-0432.CCR-05-2198.

Ranson, R and Middleton, MR and Bridgewater, J and Lee, SM and Dawson, M and Jowle, D and Halbert, G and Waller, S and McGrath, H and Gumbrell, L and McElhinney, RS and Donnelly, D and McMurray, TB and Margison, GP (2006) Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA alkyltransferas: Phase 1 safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumours. Clinical Cancer Research , 12 (5) 1577 - 1584.

Ravn, P and Patel, A and Andre, M and Bicknell, R and Begent, R and Pedley, B and Chester, K and Meyer, T (2006) Generation of Antibodies to Magic Roundabout 4, Robo4 using Phage Display. In: (Proceedings) NCRI Cancer Conference Proceedings.

Reis-Filho, JS and Westbury, C and Pierga, JY (2006) The impact of expression profiling on prognostic and predictive testing in breast cancer. J Clin Pathol , 59 (3) 225 - 231. 10.1136/jcp.2005.028324.

Rossi, C and Angelucci, A and Costantin, L and Braschi, C and Mazzantini, M and Babbini, F and Fabbri, ME and Tessarollo, L and Maffei, L and Berardi, N and Caleo, M (2006) Brain-derived neurotrophic factor (BDNF) is required for the enhancement of hippocampal neurogenesis following environmental enrichment. EUR J NEUROSCI , 24 (7) 1850 - 1856. 10.1111/j.1460-9568.2006.05059.x.

Ruszniewski, P and Delle Fave, G and Cadiot, G and Komminoth, P and Chung, D and Kos-Kudla, B and Kianmanesh, R and Hochhauser, D and Arnold, R and Ahlman, H and Pauwels, S and Kwekkeboom, DJ and Rindi, G (2006) Well-differentiated gastric tumors/carcinomas. NEUROENDOCRINOLOGY , 84 (3) 158 - 164. 10.1159/000098007.

S

Sainz-Pastor, N and Tolner, B and Huhalov, A and Kogelberg, H and Lee, YC and Zhu, DL and Begent, RHJ and Chester, KA (2006) Deglycosylation to obtain stable and homogeneous Pichia pastoris-expressed N-A1 domains of carcinoembryonic antigen. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES , 39 (1-3) 141 - 150. 10.1016/j.ijbiomac.2006.03.022.

Saunders, MI and Rojas, A (2006) Burning issues in CERT. In: RADIOTHERAPY AND ONCOLOGY. (pp. S19 - S19).

Shah, T and Hochhauser, D and Frow, R and Quaglia, A and Dhillon, AP and Caplin, ME (2006) Epidermal growth factor receptor expression and activation in neuroendocrine tumours. J NEUROENDOCRINOL , 18 (5) 355 - 360. 10.1111/j.1365-2826.2006.01425.x.

Shanley, S and McReynolds, K and Ardern, JA and Ahern, R and Fernando, I and Yarnold, J and Evans, G and Eccles, D and Hodgson, S and Ashley, S and Ashcroft, L and Tutt, A and Bancroft, E1 and Pierce, L and Short, S and Gui, GATBUOTRMHT and Barr, L and Baildam, A and Howell, T and Royle, G and Easton, DAER (2006) Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United Kingdom. Clinical Cancer Research , 1 (12) 7025 - 7032.

Shanley, SBKS and S Evans G Tutt, AH and S Powles, TASA and R Easton D and Eeles, R (2006) Acute Chemotherapy related toxicity is not increased in BRCA1 and BRCA2 mutation carriers treated for breast cancer in the UK. Clinical Cancer Research

Shaw, H and Plummer, R and Vidal, L and Perrett, R and Pilkington, M and Temple, G and Fong, P and Amelsberg, A and Calvert, H and De Bono, J (2006) A phase I dose escalation study of BIBW 2992, an irreversible dual EGFR/HER2 receptor tyrosine kinase inhibitor, in patients with advanced solid tumours. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 127S - 127S). AMER SOC CLINICAL ONCOLOGY

Short, S (2006) UNSPECIFIED In: (Proceedings) 3rd International Conference on Translational Research and Preclinical Strategies in Radiation Oncology.

Short, S (2006) BBC 6 O'Clock news. UNSPECIFIED

Short, SC and Bourne, S and Martindale, C and Johnston, P (2006) DNA repair after clinical radiation doses in gliomas and normal human astrocytes. In: NEURO-ONCOLOGY. (pp. 310 - 310).

Sizer, B and Makris, A and Barone, C and Mainwaring, P and Eggleton, P (2006) QoL and resource use analysis of tegafur-uracil/LV or 5-FU/LV in first-line metastatic colorectal cancer (mCRC): Final results of a multicenter phase II study. In: Journal of Clinical Oncology. (pp. 178S - 178S).

Soffietti, R and Cornu, P and Delattre, JY and Grant, R and Graus, F and Grisold, W and Heimans, J and Hildebrand, J and Hoskin, P and Kalljo, M and Krauseneck, P and Marosi, C and Siegal, T and Vecht, C (2006) EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. EUROPEAN JOURNAL OF NEUROLOGY , 13 (7) 674 - 681.

Stephens, R and Hoskin, P (2006) Clinical trials and modern advertising: The Lung Cancer Trials Flowchart. ELSEVIER SCIENCE LONDON, 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND

T

Thornton, AD and Ravn, P and Winslet, M and Chester, K (2006) Angiogenesis inhibition with bevacizumab and the surgical management of colorectal cancer. BRIT J SURG , 93 (12) 1456 - 1463. 10.1002/bjs.5624.

Tolner, B and Hillyer, T and Smith, L and Begent, RHJ and Contreras, R and Chester, KA (2006) A Recombinant Antibody-Enzyme Fusion Protein Produced in Pichia Pastoris in Compliance with EU Clinical Trials Directive for Phase I/II Cancer Trials. In: (Proceedings) NCRI Cancer Conference Proceedings.

Tolner, B and Smith, L and Begent, RHJ and Chester, KA (2006) Expanded-bed adsorption immobilized-metal affinity chromatography. NAT PROTOC , 1 (3) 1213 - 1222. 10.1038/nprot.2006.127.

Tolner, B and Smith, L and Begent, RHJ and Chester, KA (2006) Production of recombinant protein in Pichia pastoris by fermentation. NAT PROTOC , 1 (2) 1006 - 1021. 10.1038/nprot.2006.126.

V

Venables, K and Miles, EA and Aird, EGA and Hoskin, PJ (2006) What is the optimum breast plan: a study based on the START trial plans. British Journal of Radiology , 79 (945) 734 - 739.

Vukmanovic-Stejic, M and Zhang, Y and Cook, JE and Fletcher, JM and McQuaid, A and Masters, JE and Rustin, MHA and Taams, LS and Beverley, PCL and Macallan, DC and Akbar, AN (2006) Human CD4(+)CD25(hi)Foxp3(+) regulatory T cells are derived by rapid turnover of memory populations in vivo. J CLIN INVEST , 116 (9) 2423 - 2433. 10.1172/JCI28941.

W

Wallace, DL and Berard, M and Soares, MVD and Oldham, J and Cook, JE and Akbar, AN and Tough, DF and Beverley, PCL (2006) Prolonged exposure of naive CD8(+) T cells to interleukin-7 or interleukin-15 stimulates proliferation without differentiation or loss of telomere length. IMMUNOLOGY , 119 (2) 243 - 253. 10.1111/j.1365-2567.2006.02429.x.

Wells, G and Martin, CRH and Howard, PW and Sands, ZA and Laughton, CA and Tiberghien, A and Woo, CK and Masterson, LA and Stephenson, MJ and Hartley, JA and Jenkins, TC and Shnyder, SD and Loadman, PM and Waring, MJ and Thurston, DE (2006) Design, synthesis, and biophysical and biological evaluation of a series of Pyrrolobenzodiazepine - Poly(N-methylpyrrole) conjugates. J MED CHEM , 49 (18) 5442 - 5461. 10.1021/jm051199z.

Whelan, J and Bielack, S and Marina, N and Smeland, S and Bernstein, M (2006) . EURAMOS 1 - international randomised trial in a rare cancer: last of a soon-to-be extinct species or hope for the future? In: SIOP XXXVII meeting, Geneva Sept 2006. Ped Blood Cancer 2006;47(4):424.

Whelan, J and Dolbear, C and Davies, E and Moller, H (2006) Where do teenagers and young adults receive treatment for cancer? In: UK Association of Cancer Registries and Netherlands Cancer Registry Conference, Amsterdam, October 2006.

Whelan, J and McTiernan, A and Weston, C and Douglas, C and Grimer, R and Cassoni, A and Paulussen, M and Jurgens, H and Craft, A and Lewis, I (2006) Consequences of different approaches to local treatment of Ewing's sarcoma within an international randomised controlled trial: Analysis of EICESS-92. In: Journal of Clinical Oncology. (pp. 528S - 528S).

Whelan, J and Seddon, B and Perisoglou, M (2006) Management of osteosarcoma. Curr Treat Options Oncol , 7 (6) 444 - 455.

Whelan, JS and Cassoni, AM and Pollock, R (2006) Bone. In: Price, P and Sikora, K, (eds.) Treatment of Cancer. : London.

Whelan, JS and McTiernan, A and Weston, C and Douglas, C and Grimer, R and Cassoni, A and Spooner, D and Paulussen, M and Jurgens, H and Craft, A and Lewis, I (2006) Consequences of different approaches to local treatment of Ewing’s sarcoma within an international randomised controlled trial: analysis of EICESS-92. In: ASCO, Atlanta, June 2006.

Whelan, JS and Seddon, BM and Perisoglou, M (2006) Current Management of Osteosarcoma. Current Treatment Options in Oncology , 7 444 - 455.

Wilson, GD and Saunders, MI and Dische, S and Daley, FM and Buffa, FM and Richman, PI and Bentzen, SM (2006) Pre-treatment proliferation and the outcome of conventional and accelerated radiotherapy. EUROPEAN JOURNAL OF CANCER , 42 (3) 363 - 371.

Z

Zhao, Y and Thomas, HD and Batey, MA and Cowell, IG and Richardson, CJ and Griffin, RJ and Calvert, AH and Newell, DR and Smith, GCM and Curtin, NJ (2006) Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441. CANCER RES , 66 (10) 5354 - 5362. 10.1158/0008-5472.CAN-05-4275.

This list was generated on Thu May 23 09:29:12 2013 BST.